Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
ArQule |
---|---|
Information provided by: | ArQule |
ClinicalTrials.gov Identifier: | NCT00358930 |
This is a Phase 2, multi-center, open label study of ARQ 501 in patients with locally advanced, recurrent or metastatic squamous cell cancer of the head and neck (SCCHN).
Condition | Intervention | Phase |
---|---|---|
Head and Neck Neoplasms Carcinoma, Squamous Cell |
Drug: ARQ 501 |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Official Title: | A Phase 2 Study of ARQ 501 in Patients With Locally Advanced, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck |
Estimated Enrollment: | 60 |
Study Start Date: | July 2006 |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, Alabama | |
University of South Alabama | |
Mobile, Alabama, United States, 36693 | |
United States, California | |
Norris Comprehensive Cancer Center | |
Los Angeles, California, United States, 90089-0178 | |
LA County Hospital | |
Los Angeles, California, United States, 90033 | |
United States, Illinois | |
University of Chicago Medical Center | |
Chicago, Illinois, United States, 60637 | |
United States, Massachusetts | |
Dana-Farber Cancer Institute | |
Boston, Massachusetts, United States, 02115 | |
Dana-Farber | |
Boston, Massachusetts, United States, 02218 | |
United States, Missouri | |
Washington University School of Medicine | |
St. Louis, Missouri, United States, 63110 | |
United States, New York | |
New York Oncology Hematology | |
Albany, New York, United States, 12208 | |
United States, Texas | |
Mary Crowley Medical Research Center | |
Dallas, Texas, United States, 75201 |
Study ID Numbers: | ARQ 501-208 |
Study First Received: | July 28, 2006 |
Last Updated: | March 19, 2008 |
ClinicalTrials.gov Identifier: | NCT00358930 |
Health Authority: | United States: Food and Drug Administration |
squamous cell carcinoma of the head and neck |
Epidermoid carcinoma Beta-lapachone Squamous cell carcinoma Head and Neck Neoplasms Carcinoma, squamous cell Neoplasms, Squamous Cell |
Carcinoma, Squamous Cell Carcinoma, squamous cell of head and neck Recurrence Neoplasms, Glandular and Epithelial Carcinoma |
Neoplasms Neoplasms by Site Neoplasms by Histologic Type |